HRTS ETF (Tema Heart & Health ETF) is managed by Tema Global Limited with $54.8M in net assets. HRTS expense ratio is 0.75%, holding 45 positions across sectors including Health Care, Unknown, Other. Inception date: 2023-11-20.

HRTS performance shows a YTD return of 2.45%. The 1-year return is 28.77%. HRTS dividend yield stands at 1.30%, paid annually.

HRTS top holdings include Eli Lilly And Company (11.7%), United Health Group (5.5%), Novo Nordisk A/S-B Sedol Bp6Kmj1 (5.3%), Thermo Fisher Scientific Inc (4.4%), Roche Holding Ag Sponsored Adr (4.1%). View all HRTS holdings, sector breakdown, or dividend history.

HRTS can be compared against other funds using the overlap calculator or side-by-side comparison tool. HRTS alternatives are available via the screener, along with tax-loss harvesting opportunities.